Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2699 USD | +6.98% | -11.71% | -85.17% |
15/04 | Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives | CI |
12/04 | Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-85.17% | 4.99M | |
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |
- Stock Market
- Equities
- PRTG Stock
- News Portage Biotech Inc.
- Oppenheimer Adjusts Portage Biotech Price Target to $18 From $26, Maintains Outperform Rating